{"pmid":32315282,"title":"Estimation of Coronavirus Disease Case-Fatality Risk in Real Time.","text":["Estimation of Coronavirus Disease Case-Fatality Risk in Real Time.","We ran a simulation comparing 3 methods to calculate case-fatality risk for coronavirus disease using parameters described in previous studies. Case-fatality risk calculated from these methods all are biased at the early stage of the epidemic. When comparing real-time case-fatality risk, the current trajectory of the epidemic should be considered.","Emerg Infect Dis","Ge, Yang","Sun, Shengzhi","32315282"],"abstract":["We ran a simulation comparing 3 methods to calculate case-fatality risk for coronavirus disease using parameters described in previous studies. Case-fatality risk calculated from these methods all are biased at the early stage of the epidemic. When comparing real-time case-fatality risk, the current trajectory of the epidemic should be considered."],"journal":"Emerg Infect Dis","authors":["Ge, Yang","Sun, Shengzhi"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32315282","week":"202017|Apr 20 - Apr 26","doi":"10.3201/eid2608.201093","keywords":["2019 novel coronavirus disease","covid-19","sars","sars-cov-2","coronavirus","coronavirus disease","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"source":"PubMed","topics":["Epidemic Forecasting"],"weight":1,"_version_":1664714520204935168,"score":8.518259,"similar":[{"pmid":32168463,"title":"Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality.","text":["Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality.","We estimated the case-fatality risk for 2019 novel coronavirus disease cases in China (3.5%); China, excluding Hubei Province (0.8%); 82 countries, territories, and areas (4.2%); and on a cruise ship (0.6%). Lower estimates might be closest to the true value, but a broad range of 0.25%-3.0% probably should be considered.","Emerg Infect Dis","Wilson, Nick","Kvalsvig, Amanda","Barnard, Lucy Telfar","Baker, Michael G","32168463"],"abstract":["We estimated the case-fatality risk for 2019 novel coronavirus disease cases in China (3.5%); China, excluding Hubei Province (0.8%); 82 countries, territories, and areas (4.2%); and on a cruise ship (0.6%). Lower estimates might be closest to the true value, but a broad range of 0.25%-3.0% probably should be considered."],"journal":"Emerg Infect Dis","authors":["Wilson, Nick","Kvalsvig, Amanda","Barnard, Lucy Telfar","Baker, Michael G"],"date":"2020-03-14T11:00:00Z","year":2020,"_id":"32168463","week":"202011|Mar 09 - Mar 15","doi":"10.3201/eid2606.200320","keywords":["2019 novel coronavirus disease","covid-19","sars-cov-2","case-fatality risk","coronaviruses","pandemic","respiratory diseases","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"source":"PubMed","topics":["Epidemic Forecasting"],"weight":1,"locations":["China","China","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640874725769216,"score":202.84938},{"pmid":32294051,"title":"Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2.","text":["Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2.","Most reverse transcription PCR protocols for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) include 2-3 targets for detection. We developed a triplex, real-time reverse transcription PCR for SARS-CoV-2 that maintained clinical performance compared with singleplex assays. This protocol could streamline detection and decrease reagent use during current high SARS-CoV-2 testing demands.","Emerg Infect Dis","Waggoner, Jesse J","Stittleburg, Victoria","Pond, Renee","Saklawi, Youssef","Sahoo, Malaya K","Babiker, Ahmed","Hussaini, Laila","Kraft, Colleen S","Pinsky, Benjamin A","Anderson, Evan J","Rouphael, Nadine","32294051"],"abstract":["Most reverse transcription PCR protocols for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) include 2-3 targets for detection. We developed a triplex, real-time reverse transcription PCR for SARS-CoV-2 that maintained clinical performance compared with singleplex assays. This protocol could streamline detection and decrease reagent use during current high SARS-CoV-2 testing demands."],"journal":"Emerg Infect Dis","authors":["Waggoner, Jesse J","Stittleburg, Victoria","Pond, Renee","Saklawi, Youssef","Sahoo, Malaya K","Babiker, Ahmed","Hussaini, Laila","Kraft, Colleen S","Pinsky, Benjamin A","Anderson, Evan J","Rouphael, Nadine"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32294051","week":"202016|Apr 13 - Apr 19","doi":"10.3201/eid2607.201285","keywords":["2019 novel coronavirus disease","covid-19","sars","sars-cov-2","coronavirus","coronavirus disease","molecular detection","rrt-pcr","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664636192633651201,"score":172.7084},{"pmid":32168464,"title":"Estimating Risk for Death from 2019 Novel Coronavirus Disease, China, January-February 2020.","text":["Estimating Risk for Death from 2019 Novel Coronavirus Disease, China, January-February 2020.","Since December 2019, when the first case of 2019 novel coronavirus disease (COVID-19) was identified in the city of Wuhan in the Hubei Province of China, the epidemic has generated tens of thousands of cases throughout China. As of February 28, 2020, the cumulative number of reported deaths in China was 2,858. We estimated the time-delay adjusted risk for death from COVID-19 in Wuhan, as well as for China excluding Wuhan, to assess the severity of the epidemic in the country. Our estimates of the risk for death in Wuhan reached values as high as 12% in the epicenter of the epidemic and approximately 1% in other, more mildly affected areas. The elevated death risk estimates are probably associated with a breakdown of the healthcare system, indicating that enhanced public health interventions, including social distancing and movement restrictions, should be implemented to bring the COVID-19 epidemic under control.","Emerg Infect Dis","Mizumoto, Kenji","Chowell, Gerardo","32168464"],"abstract":["Since December 2019, when the first case of 2019 novel coronavirus disease (COVID-19) was identified in the city of Wuhan in the Hubei Province of China, the epidemic has generated tens of thousands of cases throughout China. As of February 28, 2020, the cumulative number of reported deaths in China was 2,858. We estimated the time-delay adjusted risk for death from COVID-19 in Wuhan, as well as for China excluding Wuhan, to assess the severity of the epidemic in the country. Our estimates of the risk for death in Wuhan reached values as high as 12% in the epicenter of the epidemic and approximately 1% in other, more mildly affected areas. The elevated death risk estimates are probably associated with a breakdown of the healthcare system, indicating that enhanced public health interventions, including social distancing and movement restrictions, should be implemented to bring the COVID-19 epidemic under control."],"journal":"Emerg Infect Dis","authors":["Mizumoto, Kenji","Chowell, Gerardo"],"date":"2020-03-14T11:00:00Z","year":2020,"_id":"32168464","week":"202011|Mar 09 - Mar 15","doi":"10.3201/eid2606.200233","keywords":["2019 novel coronavirus disease","cfr","covid-19","china","hubei","sars-cov-2","wuhan","case-fatality ratio","coronavirus","death","mortality","outbreak","respiratory diseases","risk","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"source":"PubMed","topics":["Epidemic Forecasting","Prevention"],"weight":1,"locations":["Wuhan","China","China","Wuhan","China","Wuhan","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640874724720640,"score":156.91713},{"pmid":32324118,"title":"Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States.","text":["Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States.","We estimated that 45.4% of US adults are at increased risk for complications from coronavirus disease because of cardiovascular disease, diabetes, respiratory disease, hypertension, or cancer. Rates increased by age, from 19.8% for persons 18-29 years of age to 80.7% for persons >80 years of age, and varied by state, race/ethnicity, health insurance status, and employment.","Emerg Infect Dis","Adams, Mary L","Katz, David L","Grandpre, Joseph","32324118"],"abstract":["We estimated that 45.4% of US adults are at increased risk for complications from coronavirus disease because of cardiovascular disease, diabetes, respiratory disease, hypertension, or cancer. Rates increased by age, from 19.8% for persons 18-29 years of age to 80.7% for persons >80 years of age, and varied by state, race/ethnicity, health insurance status, and employment."],"journal":"Emerg Infect Dis","authors":["Adams, Mary L","Katz, David L","Grandpre, Joseph"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32324118","week":"202017|Apr 20 - Apr 26","doi":"10.3201/eid2608.200679","keywords":["covid-19","sars-cov-2","united states","chronic conditions","complications","coronavirus disease","infection","population-based estimates","respiratory infections","risk factors","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"source":"PubMed","topics":["Epidemic Forecasting"],"weight":1,"locations":["US","Coronavirus Disease","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"_version_":1664895932847620096,"score":153.3566},{"pmid":32330410,"title":"Doubling Time of the COVID-19 Epidemic by Province, China.","text":["Doubling Time of the COVID-19 Epidemic by Province, China.","In China, the doubling time of the coronavirus disease epidemic by province increased during January 20-February 9, 2020. Doubling time estimates ranged from 1.4 (95% CI 1.2-2.0) days for Hunan Province to 3.1 (95% CI 2.1-4.8) days for Xinjiang Province. The estimate for Hubei Province was 2.5 (95% CI 2.4-2.6) days.","Emerg Infect Dis","Muniz-Rodriguez, Kamalich","Chowell, Gerardo","Cheung, Chi-Hin","Jia, Dongyu","Lai, Po-Ying","Lee, Yiseul","Liu, Manyun","Ofori, Sylvia K","Roosa, Kimberlyn M","Simonsen, Lone","Viboud, Cecile","Fung, Isaac Chun-Hai","32330410"],"abstract":["In China, the doubling time of the coronavirus disease epidemic by province increased during January 20-February 9, 2020. Doubling time estimates ranged from 1.4 (95% CI 1.2-2.0) days for Hunan Province to 3.1 (95% CI 2.1-4.8) days for Xinjiang Province. The estimate for Hubei Province was 2.5 (95% CI 2.4-2.6) days."],"journal":"Emerg Infect Dis","authors":["Muniz-Rodriguez, Kamalich","Chowell, Gerardo","Cheung, Chi-Hin","Jia, Dongyu","Lai, Po-Ying","Lee, Yiseul","Liu, Manyun","Ofori, Sylvia K","Roosa, Kimberlyn M","Simonsen, Lone","Viboud, Cecile","Fung, Isaac Chun-Hai"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330410","week":"202017|Apr 20 - Apr 26","doi":"10.3201/eid2608.200219","keywords":["2019 novel coronavirus disease","covid-19","china","sars-cov-2","coronavirus","epidemiology","infectious disease transmission","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"source":"PubMed","topics":["Epidemic Forecasting"],"weight":1,"locations":["China","Hunan","Xinjiang","Hubei","Province","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664996914837323777,"score":145.03802}]}